Palforzia Level 7 Capsules

Manufacturer GREER LABORATORIES Active Ingredient Peanut Allergen Powder(pee nut AL er jen pow der) Pronunciation PAL-for-zee-uh
WARNING: Allergic reactions have happened with this drug. Rarely, some reactions can be very bad or life-threatening. Talk with the doctor.The first dose and all dose increases will be given in a doctor's office or other healthcare setting.Your doctor will give you another drug (epinephrine) to use in case of an allergic reaction. Someone else may have to give you the shot. Be sure you and other people who may need to give the shot know how and when to use it. Certain drugs may make epinephrine not work as well or raise the chance of side effects. This includes some drugs used to treat depression, heart problems, or high blood pressure. There are many drugs that interact with epinephrine. Talk with your doctor or pharmacist to make sure it is safe to take epinephrine with all of your drugs.Do not take this drug if you have very bad asthma or asthma that is not controlled. @ COMMON USES: It is used to help with allergies caused by peanuts. This drug is not for use to treat an allergic reaction.
🏷️
Drug Class
Allergen extract
🧬
Pharmacologic Class
Oral immunotherapy
🀰
Pregnancy Category
Not available
βœ…
FDA Approved
Jan 2020
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Palforzia is a medicine made from peanut protein that helps reduce the severity of allergic reactions, including life-threatening ones, if you accidentally eat peanuts. It works by slowly introducing tiny amounts of peanut to your body over time, helping your immune system get used to it. It's not a cure for peanut allergy, and you still need to avoid peanuts and carry an epinephrine auto-injector.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To ensure you get the most benefit from your medication, follow these steps:

1. Follow Your Doctor's Orders: Take this medication exactly as directed by your doctor. Read all the information provided with your medication and follow the instructions carefully.
2. Take with Food: Take your medication with a meal to help your body absorb it properly.
3. Consistent Schedule: Take your medication at the same time every day. It is recommended to take it in the evening.
4. Preparing Your Dose: Do not swallow the capsules or inhale the powder. Instead, open the capsule or sachet and mix the contents with a few spoonfuls of soft food, such as applesauce, yogurt, or pudding. Mix well, but do not mix with liquids.
5. Take Immediately: After mixing, take your dose right away. Do not store the mixture for future use.
6. Continuing Your Medication: Continue taking your medication as directed by your doctor or healthcare provider, even if you start feeling well.
7. Disposing of Leftovers: Throw away any leftover medication after taking your dose.
8. Hand Hygiene: Wash your hands after handling your medication.
9. Special Instructions for Doctor's Visits: If you are visiting your doctor for an up-dosing appointment, do not take your dose that day.

Storing and Disposing of Your Medication

Store your medication in a refrigerator or at room temperature.
If you miss a dose, call your doctor to find out what to do.
πŸ’‘

Lifestyle & Tips

  • Continue strict peanut avoidance in your diet.
  • Always carry at least two epinephrine auto-injectors and know how to use them.
  • Administer Palforzia daily with food, preferably at the same time each day.
  • Do not take Palforzia if you are sick with a fever, vomiting, diarrhea, or have uncontrolled asthma.
  • Avoid strenuous exercise for at least 3 hours after taking Palforzia.
  • Avoid hot showers or baths immediately after taking Palforzia.
  • Inform all healthcare providers, including dentists, that you are taking Palforzia.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Not indicated for initial treatment in adults. Maintenance dose of 300 mg daily may be continued in patients 18 years of age and older who have completed up-dosing.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Approved for patients 4-17 years of age. Treatment consists of three phases: Initial Dose Escalation (IDE), Up-Dosing, and Maintenance. Palforzia Level 7 Capsules contain 120 mg of peanut allergen powder. This dose is part of the Up-Dosing phase, administered daily for 2 weeks before advancing to the next dose level (160 mg), under medical supervision.
Adolescent: Approved for patients 4-17 years of age. Treatment consists of three phases: Initial Dose Escalation (IDE), Up-Dosing, and Maintenance. Palforzia Level 7 Capsules contain 120 mg of peanut allergen powder. This dose is part of the Up-Dosing phase, administered daily for 2 weeks before advancing to the next dose level (160 mg), under medical supervision.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended
Moderate: No specific dose adjustment recommended
Severe: No specific dose adjustment recommended
Dialysis: No specific considerations

Hepatic Impairment:

Mild: No specific dose adjustment recommended
Moderate: No specific dose adjustment recommended
Severe: No specific dose adjustment recommended

Pharmacology

πŸ”¬

Mechanism of Action

Palforzia is an oral immunotherapy (OIT) indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut. It works by gradually introducing increasing amounts of peanut protein to the immune system, aiming to induce desensitization. This process involves modulating the immune response, shifting from a predominantly IgE-mediated allergic response to a more tolerant state, potentially involving IgG4 antibodies and regulatory T cells, thereby reducing the severity of allergic reactions upon subsequent peanut exposure.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Not applicable (immunological effect)
Tmax: Not applicable
FoodEffect: Administer with food to reduce gastrointestinal symptoms

Distribution:

Vd: Not applicable
ProteinBinding: Not applicable
CnssPenetration: No

Elimination:

HalfLife: Not applicable
Clearance: Not applicable
ExcretionRoute: Not applicable
Unchanged: Not applicable
⏱️

Pharmacodynamics

OnsetOfAction: Gradual (over months of treatment)
PeakEffect: Achieved after completion of up-dosing and maintenance phases
DurationOfAction: Ongoing with continued daily maintenance therapy

Safety & Warnings

⚠️

BLACK BOX WARNING

Risk of Anaphylaxis: PALFORZIA can cause anaphylaxis, which may be life-threatening. Administer PALFORZIA in a healthcare setting equipped to manage anaphylaxis, and patients must be observed for at least 60 minutes following each dose in the Initial Dose Escalation phase and the first dose of each Up-Dosing level. Patients must have injectable epinephrine available for immediate use.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you or your child experience any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Trouble swallowing or speaking
Pain with swallowing
Heartburn
Chest pain or pressure
Fast heartbeat
Passing out
Dizziness
Flushing
Shortness of breath
Severe diarrhea
Stomach cramps

In children, watch for:
Unusual crying
Feeling sluggish or extremely sleepy
Pulling legs up to the stomach

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you or your child experience any of the following side effects, contact your doctor if they bother you or do not go away:

Diarrhea
Stomach pain
Upset stomach
Vomiting
Itching in the ear, mouth, or tongue
Numbness or tingling in the mouth
Throat irritation
Cough
Runny or stuffy nose
* Sneezing

This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Signs of anaphylaxis (difficulty breathing, wheezing, hives, swelling, dizziness, severe stomach pain)
  • Persistent or worsening gastrointestinal symptoms (e.g., abdominal pain, vomiting, diarrhea)
  • Worsening asthma symptoms
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
A history of life-threatening reactions to peanuts.
Previous severe allergic reactions.
Eosinophilic esophagitis or other eosinophilic stomach or bowel diseases.
* Heart problems, lung problems, or mast cell disorders.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or adjust the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Adhere to the diet plan recommended by your doctor and continue to avoid peanuts as previously advised. Certain factors may increase your risk of an allergic reaction, so be sure to discuss the following with your doctor: alcohol consumption, illness such as a viral infection, fasting, fatigue or lack of sleep, menstrual period, or use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen.

To minimize potential risks, avoid taking this medication within 3 hours before or after exercising, or taking a hot shower or bath. If you have exercised or taken a hot shower or bath and experience symptoms such as feeling hot, sweating, or rapid breathing or heartbeat, wait until these symptoms resolve before taking your medication.

If you have asthma and experience difficulty breathing or a worsening of your asthma symptoms, contact your doctor immediately. Additionally, if you are pregnant, plan to become pregnant, or are breast-feeding, consult your doctor to discuss the potential benefits and risks of this medication to both you and your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Severe allergic reaction, potentially anaphylaxis, due to accidental ingestion of a significantly higher dose than prescribed.

What to Do:

Seek immediate emergency medical attention. Administer epinephrine if signs of anaphylaxis are present. Call 911 or your local emergency number. Call 1-800-222-1222 for poison control advice.

Drug Interactions

🚫

Contraindicated Interactions

  • Uncontrolled asthma
  • Eosinophilic esophagitis
  • Other eosinophilic gastrointestinal disease
πŸ”΄

Major Interactions

  • Beta-blockers (may exacerbate anaphylaxis and interfere with epinephrine's effects)
  • Angiotensin-converting enzyme (ACE) inhibitors (may increase risk of anaphylaxis)
🟑

Moderate Interactions

  • Antihistamines (may mask early symptoms of allergic reaction)
  • Systemic corticosteroids (may reduce efficacy of immunotherapy)
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Comprehensive allergy history and physical examination

Rationale: To confirm peanut allergy diagnosis and assess suitability for treatment.

Timing: Prior to initiation of treatment

Asthma control assessment

Rationale: Uncontrolled asthma is a contraindication; asthma must be well-controlled before and during treatment.

Timing: Prior to initiation and periodically during treatment

Epinephrine auto-injector prescription and training

Rationale: Patients must have immediate access to epinephrine and be trained on its use due to risk of anaphylaxis.

Timing: Prior to initiation and ongoing

πŸ“Š

Routine Monitoring

Monitoring for allergic reactions (e.g., anaphylaxis, oral pruritus, GI symptoms)

Frequency: During and after each dose administration (especially during IDE and Up-Dosing), and daily at home

Target: Absence of severe reactions

Action Threshold: Any signs of allergic reaction, especially severe ones, require immediate medical attention and potential dose adjustment or discontinuation.

Asthma control

Frequency: Regularly, especially before each dose increase

Target: Well-controlled asthma

Action Threshold: Worsening asthma symptoms or uncontrolled asthma requires temporary cessation of Palforzia and medical evaluation.

Adherence to dosing schedule

Frequency: Ongoing

Target: Consistent daily dosing

Action Threshold: Missed doses may require re-evaluation and potential re-initiation at a lower dose.

πŸ‘οΈ

Symptom Monitoring

  • Hives
  • Swelling (face, lips, tongue, throat)
  • Difficulty breathing or wheezing
  • Dizziness or fainting
  • Rapid heart rate
  • Pale or bluish skin
  • Severe abdominal pain, vomiting, diarrhea
  • Feeling of impending doom

Special Patient Groups

🀰

Pregnancy

No adequate and well-controlled studies of Palforzia in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus. Animal reproduction studies have not been conducted.

Trimester-Specific Risks:

First Trimester: Risk unknown, limited data.
Second Trimester: Risk unknown, limited data.
Third Trimester: Risk unknown, limited data.
🀱

Lactation

No data on the presence of peanut allergen powder in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Palforzia and any potential adverse effects on the breastfed infant from Palforzia or from the underlying maternal condition.

Infant Risk: Risk unknown, limited data. Consider potential for allergic reaction in infant if peanut protein is excreted in milk.
πŸ‘Ά

Pediatric Use

Palforzia is approved for patients 4 through 17 years of age. Safety and effectiveness have not been established in patients younger than 4 years of age. Close monitoring for adverse reactions is crucial in this population.

πŸ‘΄

Geriatric Use

Safety and effectiveness have not been established in geriatric patients (65 years of age and older). Not typically indicated for this age group.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Palforzia is NOT a cure for peanut allergy; patients must continue strict peanut avoidance and carry epinephrine.
  • All initial dose escalations and the first dose of each up-dosing level MUST be administered in a healthcare setting with anaphylaxis management capabilities.
  • Patients should avoid taking Palforzia if they are experiencing illness (e.g., fever, vomiting, diarrhea) or have uncontrolled asthma, as this increases the risk of adverse reactions.
  • Administer Palforzia with food to help mitigate gastrointestinal side effects.
  • Missed doses or extended breaks in treatment may require re-evaluation by a healthcare provider and potentially restarting at a lower dose.
  • The goal of Palforzia is to reduce the severity of reactions to accidental peanut exposure, not to enable unrestricted peanut consumption.
πŸ”„

Alternative Therapies

  • Strict peanut avoidance (current standard of care)
  • Epinephrine auto-injectors (for emergency treatment of anaphylaxis)
  • Investigational therapies (e.g., epicutaneous immunotherapy patches, other oral immunotherapies in clinical trials)
πŸ’°

Cost & Coverage

Average Cost: High (e.g., $5,000 - $10,000+ per month for treatment kits) per treatment kit
Insurance Coverage: Specialty Tier (requires prior authorization, may have high co-pays)
πŸ“š

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure your safety and the effectiveness of your treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which is a patient fact sheet that provides crucial information about its safe and effective use. It is vital to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, do not hesitate to consult with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information about the overdose, including the name of the medication taken, the amount consumed, and the time it occurred.